Every 10 minutes someone is added to the organ transplant waiting list in the US.
As of May 2021, there were over 100,000 people waiting for replacement organs across the country.
And countless more people in need of “spare parts” never even make it onto the waiting list. On average, 17 people die each day while waiting for an organ transplant.
As a result, hundreds of thousands of US deaths could be prevented or postponed with access to organ replacements.
That’s why the recent announcement of the first successful human transplant of an artificial heart in a US patient is such a big development.
The artificial heart used in the transplant was created by medical technology company Carmat, which won FDA approval for human trials just last year. Discussing the latest developments in biotech—using biology as technology—is a key focus of my year-round coaching program Abundance360.
In today’s blog, we’ll discuss how Carmat’s artificial heart works and how it fits into the broader objective of regenerative medicine.
Let’s dive in…Continue reading… “FIRST SUCCESSFUL TRANSPLANT OF A ROBOTIC HEART”